{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:27:48Z","timestamp":1790227668525,"version":"4.1.0"},"reference-count":71,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2017.0447","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:29:13Z","timestamp":1525253353000},"source":"Crossref","is-referenced-by-count":20,"title":["The Diagnosis and Treatment of Behavioral Disorders in Dementia"],"prefix":"10.3238","author":[{"given":"Torsten","family":"Kratz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2017,6,30]]},"reference":[{"key":"10.3238\/arztebl.2017.0447_ref1","unstructured":"Hessler JB, Sch\u00e4ufele M, Hendlmeier I, et al.: Behavioural and psychological symptoms in general hospital patients with dementia, distress for nursing staff and complications in care: results of the General Hospital Study. Epidemiol Psychiatr Sci 2017; 9: 1\u201310"},{"key":"10.3238\/arztebl.2017.0447_ref2","unstructured":"Deuschl G, Maier W: Deutsche Gesellschaft f\u00fcr Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), Deutsche Gesellschaft f\u00fcr Neurologie (DGN): Diagnose- und Behandlungsleitlinie Demenz \u2013 Interdisziplin\u00e4re S3 Praxisleitlinien 2016. www.dgn.org\/images\/red_leitlinien\/LL_2016\/PDFs_Download\/038013_LL_Demenzen_2016.pdf (last accessed on 24 February 2017)."},{"key":"10.3238\/arztebl.2017.0447_ref3","doi-asserted-by":"crossref","unstructured":"Ballard CG, Gauthier S, Cummings JL, et al.: Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 2009; 5: 245\u201355","DOI":"10.1038\/nrneurol.2009.39"},{"key":"10.3238\/arztebl.2017.0447_ref4","doi-asserted-by":"crossref","unstructured":"Hoyer S: The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 2002; 109: 341\u201360","DOI":"10.1007\/s007020200028"},{"key":"10.3238\/arztebl.2017.0447_ref5","doi-asserted-by":"crossref","unstructured":"de Vugt ME, Stevens F, Aalten P, Lousberg R, Jaspers N, Verhey FR: A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia. Int Psychogeriatr 2005; 17: 577\u201389","DOI":"10.1017\/S1041610205002292"},{"key":"10.3238\/arztebl.2017.0447_ref6","doi-asserted-by":"crossref","unstructured":"Husebo BS, Ballard C, Aarsland D: Pain treatment of agitation in patients with dementia: a systematic review. Int J Geriatr Psychiatry 2011; 26: 1012\u20138","DOI":"10.1002\/gps.2649"},{"key":"10.3238\/arztebl.2017.0447_ref7","doi-asserted-by":"crossref","unstructured":"Vigen CL, Mack WJ, Keefe RS, et al.: Cognitive effects of atypical antipsychotic medications in patients with Alzheimer\u2018s disease: outcomes from CATIE-AD. Am J Psychiatry 2011; 168: 831\u20139","DOI":"10.1176\/appi.ajp.2011.08121844"},{"key":"10.3238\/arztebl.2017.0447_ref8","doi-asserted-by":"crossref","unstructured":"Huff W, Steckel R, Sitzer M: [Poststroke depression: risk factors and effects on the course of the stroke]. Nervenarzt 2003; 74: 104\u201314","DOI":"10.1007\/s00115-002-1417-x"},{"key":"10.3238\/arztebl.2017.0447_ref9","doi-asserted-by":"crossref","unstructured":"Kountouras J, Tsolaki M, Gavalas E, et al.: Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006; 66: 938\u201340","DOI":"10.1212\/01.wnl.0000203644.68059.5f"},{"key":"10.3238\/arztebl.2017.0447_ref10","doi-asserted-by":"crossref","unstructured":"Yaffe K, Falvey CM, Hamilton N, et al.: Health ABC Study. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013; 173: 1300\u20136","DOI":"10.1001\/jamainternmed.2013.6176"},{"key":"10.3238\/arztebl.2017.0447_ref11","unstructured":"Sattel H: H\u00e4ufigkeit und Bedeutung \u201enicht kognitiver\u201c Symptome bei der Demenz vom Alzheimer-Typ. Zeitschrift f\u00fcr Gerontologie 1993; 26: 275\u20139"},{"key":"10.3238\/arztebl.2017.0447_ref12","doi-asserted-by":"crossref","unstructured":"Rainer MK, Mucke HA, Masching AJ, et al.: Zeitgem\u00e4\u00dfes Management von nicht kognitiven Symptomen bei Demenz. Psychiatr Prax 2005; 32: 31\u20138","DOI":"10.1055\/s-2003-814885"},{"key":"10.3238\/arztebl.2017.0447_ref13","unstructured":"Kraepelin E: Der Verfolgungswahn der Schwerh\u00f6rigen. In: Kraepelin E. Psychiatrie. Ein Lehrbuch f\u00fcr Studierende und \u00c4rzte. Leipzig: Barth 1915; 1441\u20138."},{"key":"10.3238\/arztebl.2017.0447_ref14","doi-asserted-by":"crossref","unstructured":"B\u00f6wing G, Schmidt K, Schr\u00f6der S: Erf\u00fcllen kriegstraumatisierte, gerontopsychiatrische Patienten PTSD-Kriterien? Psychiat Prax 2007; 34:\u00a0122\u20138","DOI":"10.1055\/s-2006-951842"},{"key":"10.3238\/arztebl.2017.0447_ref15","doi-asserted-by":"crossref","unstructured":"Kolanowski AM, Whall AL: Life-span perspective of personality in dementia. Image J Nurs Sch 1996; 28: 315\u201320","DOI":"10.1111\/j.1547-5069.1996.tb00380.x"},{"key":"10.3238\/arztebl.2017.0447_ref16","doi-asserted-by":"crossref","unstructured":"McKeith IG, Dickson DW, Lowe J, et al.: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863\u201372","DOI":"10.1212\/WNL.65.12.1992-a"},{"key":"10.3238\/arztebl.2017.0447_ref17","doi-asserted-by":"crossref","unstructured":"Kratz T: Delir bei Demenz. Z Gerontol Geriat 2007; 40: 1\u20138","DOI":"10.1007\/s00391-007-0435-5"},{"key":"10.3238\/arztebl.2017.0447_ref18","unstructured":"Kratz T, Heinrich M, Schlau\u00df E, Diefenbacher A: The prevention of postoperative delirium \u2014 a prospective intervention with psychogeriatric liaison on surgical wards in a general hospital. Dtsch Arztebl Int 2015; 112: 289\u201396"},{"key":"10.3238\/arztebl.2017.0447_ref19","unstructured":"Romero B, Eder G: Selbst-Erhaltungs-Therapie (SET): Konzept einer neuropsychologischen Therapie bei Alzheimer-Kranken. Zeitschrift f\u00fcr Gerontopsychologie und -psychiatrie 1992; 5: 267\u201382."},{"key":"10.3238\/arztebl.2017.0447_ref20","doi-asserted-by":"crossref","unstructured":"Carriere I, Fourrier-Reglat A, Dartigues JF, et al.: Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the\u00a03-city study. Arch Intern Med 2009; 169: 1317\u201324","DOI":"10.1001\/archinternmed.2009.229"},{"key":"10.3238\/arztebl.2017.0447_ref21","doi-asserted-by":"crossref","unstructured":"Holt S, Schmiedl S, Th\u00fcrmann PA: Potentially inappropriate medications in the elderly: The PRISCUS List. Dtsch Arztebl Int 2010; 107: 543\u201351","DOI":"10.3238\/arztebl.2010.0543"},{"key":"10.3238\/arztebl.2017.0447_ref22","doi-asserted-by":"crossref","unstructured":"Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934\u201343","DOI":"10.1001\/jama.294.15.1934"},{"key":"10.3238\/arztebl.2017.0447_ref23","doi-asserted-by":"crossref","unstructured":"Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14: 191\u2013210","DOI":"10.1097\/01.JGP.0000200589.01396.6d"},{"key":"10.3238\/arztebl.2017.0447_ref24","doi-asserted-by":"crossref","unstructured":"Chan WC, Lam LC, Choy CN, Leung VP, Li SW, Chiu HF: A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 2001; 16: 1156\u201362","DOI":"10.1002\/gps.504"},{"key":"10.3238\/arztebl.2017.0447_ref25","doi-asserted-by":"crossref","unstructured":"Suh GH, Son HG, Ju YS, et al.: A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances. Am J Geriatr Psychiatry 2004; 12: 509\u201316","DOI":"10.1097\/00019442-200409000-00009"},{"key":"10.3238\/arztebl.2017.0447_ref26","doi-asserted-by":"crossref","unstructured":"Morgante L, Epifanio A, Spina E, et al.: Quetiapine and clozapine in Parkinsonian patients with dopaminergic psychosis. Clin Neuropharmacol 2004; 27: 153\u20136","DOI":"10.1097\/01.wnf.0000136891.17006.ec"},{"key":"10.3238\/arztebl.2017.0447_ref27","doi-asserted-by":"crossref","unstructured":"Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J: Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158: 892\u20138","DOI":"10.1176\/appi.ajp.158.6.892"},{"key":"10.3238\/arztebl.2017.0447_ref28","doi-asserted-by":"crossref","unstructured":"Tariot PN, Erb R, Podgorski CA, et al.: Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998; 155: 54\u201361","DOI":"10.1176\/ajp.155.1.54"},{"key":"10.3238\/arztebl.2017.0447_ref29","doi-asserted-by":"crossref","unstructured":"Lonergan E, Luxenberg J: Valproate preparations for agitation in dementia. Cochrane Database Syst Rev 2009; (3): CD003945","DOI":"10.1002\/14651858.CD003945.pub3"},{"key":"10.3238\/arztebl.2017.0447_ref30","doi-asserted-by":"crossref","unstructured":"Doody RS, Stevens JC, Beck C, et al.: Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1154\u201366","DOI":"10.1212\/WNL.56.9.1154"},{"key":"10.3238\/arztebl.2017.0447_ref31","doi-asserted-by":"crossref","unstructured":"Taragano FE, Lyketsos CG, Mangone CA, Allegri RF, Comesana-Diaz E: A double-blind, randomized, fixeddose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer\u2018s disease. Psychosomatics 1997; 38: 246\u201352","DOI":"10.1016\/S0033-3182(97)71461-0"},{"key":"10.3238\/arztebl.2017.0447_ref32","doi-asserted-by":"crossref","unstructured":"Nyth AL, Gottfries CG, Lyby K, et al.: A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 1992; 86: 138\u201345","DOI":"10.1111\/j.1600-0447.1992.tb03242.x"},{"key":"10.3238\/arztebl.2017.0447_ref33","doi-asserted-by":"crossref","unstructured":"Sultzer DL, Gray KF, Gunay I, Berisford MA, Mahler ME: A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry 1997; 5: 60\u20139","DOI":"10.1097\/00019442-199705010-00008"},{"key":"10.3238\/arztebl.2017.0447_ref34","doi-asserted-by":"crossref","unstructured":"Roth M, Mountjoy CQ, Amrein R: Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry 1996; 168: 149\u201357","DOI":"10.1192\/bjp.168.2.149"},{"key":"10.3238\/arztebl.2017.0447_ref35","doi-asserted-by":"crossref","unstructured":"Brijoux T, Kricheldorff C, H\u00fcll M, et al.: Supporting families living with dementia in rural areas\u2014a randomized controlled trial of quality of life improvement using qualified volunteers. Dtsch Arztebl Int 2016; 113: 681\u20137","DOI":"10.3238\/arztebl.2016.0681"},{"key":"10.3238\/arztebl.2017.0447_ref36","doi-asserted-by":"crossref","unstructured":"Feil N, Altman R: Validation theory and the myth of the therapeutic lie. Am J Alzheimers Dis Other Demen 2004; 19: 77\u20138","DOI":"10.1177\/153331750401900214"},{"key":"10.3238\/arztebl.2017.0447_ref37","doi-asserted-by":"crossref","unstructured":"Neal M, Briggs M: Validation therapy for dementia. Cochrane Database Syst Rev 2003; (3): CD001394","DOI":"10.1002\/14651858.CD001394"},{"key":"10.3238\/arztebl.2017.0447_ref38","doi-asserted-by":"crossref","unstructured":"Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382\u20139","DOI":"10.1192\/bjp.134.4.382"},{"key":"10.3238\/arztebl.2017.0447_ref39","doi-asserted-by":"crossref","unstructured":"Warden V, Hurley AC Volicer L: Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc 2003; 4: 9 \u201315","DOI":"10.1097\/01.JAM.0000043422.31640.F7"},{"key":"10.3238\/arztebl.2017.0447_ref40","unstructured":"Brunner C, Spiegel R: Eine Validierungsstudie mit der NOSGER, einem neuen Beurteilungsinstrument f\u00fcr die Psychogeriatrie. Zeitschrift f\u00fcr klinische Psychologie 1990; 19: 211\u201329."},{"key":"10.3238\/arztebl.2017.0447_ref41","doi-asserted-by":"crossref","unstructured":"Cohen-Mansfield J, Werner P, Marx MS: An observational study of agitation in agitated nursing home residents. Int Psychogeriatr 1989; 1: 153\u201365","DOI":"10.1017\/S1041610289000165"},{"key":"10.3238\/arztebl.2017.0447_ref42","doi-asserted-by":"crossref","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308\u201314","DOI":"10.1212\/WNL.44.12.2308"},{"key":"10.3238\/arztebl.2017.0447_ref43","doi-asserted-by":"crossref","unstructured":"Auer SR, Monteiro I, Reisberg B: The Empirical Pathology in Alzheimer\u2018s Disease (E-BEHAVE-AD) Rating Scale. International Psychogeriatrics 1996; 8: 247\u201366","DOI":"10.1017\/S1041610296002621"},{"key":"10.3238\/arztebl.2017.0447_ref44","unstructured":"Wooltorton E: Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. CMAJ 2002; 167: 1269\u201370"},{"key":"10.3238\/arztebl.2017.0447_ref45","doi-asserted-by":"crossref","unstructured":"Lonergan E, Luxenberg J, Colford J: Haloperidol for agitation in dementia. Cochrane Database Syst Rev 2002; (2): CD002852","DOI":"10.1002\/14651858.CD002852"},{"key":"10.3238\/arztebl.2017.0447_ref46","doi-asserted-by":"crossref","unstructured":"Ballard C, Waite J, Birks J: Atypical antipsychotics for aggression and psychosis in Alzheimer\u2019s disease (Review). Cochrane Database Syst Rev 2006; (1): CD003476","DOI":"10.1002\/14651858.CD003476.pub2"},{"key":"10.3238\/arztebl.2017.0447_ref47","doi-asserted-by":"crossref","unstructured":"Devanand DP, Marder K, Michaels KS, et al.: A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer\u2018s disease. Am J Psychiatry 1998; 155: 1512\u201320","DOI":"10.1176\/ajp.155.11.1512"},{"key":"10.3238\/arztebl.2017.0447_ref48","doi-asserted-by":"crossref","unstructured":"Birks J, Harvey RJ: Donepezil for dementia due to Alzheimer\u2018s disease. Cochrane Database Syst Rev 2006; (1): CD001190","DOI":"10.1002\/14651858.CD001190.pub2"},{"key":"10.3238\/arztebl.2017.0447_ref49","doi-asserted-by":"crossref","unstructured":"Cummings JL, Schneider L, Tariot PN, et al.: Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer\u2018s disease. Am J Psychiatry 2004; 161: 532\u20138","DOI":"10.1176\/appi.ajp.161.3.532"},{"key":"10.3238\/arztebl.2017.0447_ref50","doi-asserted-by":"crossref","unstructured":"Emre M, Aarsland D, Albanese A, et al.: Rivastigmine for dementia associated with Parkinson\u2018s disease. N Engl J Med 2004; 351: 2509\u201318","DOI":"10.1056\/NEJMoa041470"},{"key":"10.3238\/arztebl.2017.0447_ref51","doi-asserted-by":"crossref","unstructured":"McKeith I, Del Ser T, Spano P, et al.: Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031\u20136","DOI":"10.1016\/S0140-6736(00)03399-7"},{"key":"10.3238\/arztebl.2017.0447_ref52","doi-asserted-by":"crossref","unstructured":"McShane R, Areosa Sastre A, Minakaran N: Memantine for dementia. Cochrane Database Syst Rev 2006; (2): CD003154","DOI":"10.1002\/14651858.CD003154.pub5"},{"key":"10.3238\/arztebl.2017.0447_ref53","doi-asserted-by":"crossref","unstructured":"Emre M, Tsolaki M, Bonuccelli U, et al.: Memantine for patients with Parkinson\u2018s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9: 969\u201377","DOI":"10.1016\/S1474-4422(10)70194-0"},{"key":"10.3238\/arztebl.2017.0447_ref54","doi-asserted-by":"crossref","unstructured":"Mintzer JE, Tune LE, Breder CD, et al.: Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. Am J Geriatr Psychiatry 2007; 15: 918\u201331","DOI":"10.1097\/JGP.0b013e3181557b47"},{"key":"10.3238\/arztebl.2017.0447_ref55","doi-asserted-by":"crossref","unstructured":"Sultzer DL, Davis SM, Tariot PN, et al.: Clinical symptom responses to atypical antipsychotic medications in Alzheimer\u2018s disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry 2008; 165: 844\u201354","DOI":"10.1176\/appi.ajp.2008.07111779"},{"key":"10.3238\/arztebl.2017.0447_ref56","doi-asserted-by":"crossref","unstructured":"De Vasconcelos Cunha UG, Lopes Rocha F, Avila de Melo R, et al.: A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia. Dement Geriatr Cogn Disord 2007; 24: 36\u201341","DOI":"10.1159\/000102570"},{"key":"10.3238\/arztebl.2017.0447_ref57","doi-asserted-by":"crossref","unstructured":"Boyle PA, Malloy PF: Treating apathy in Alzheimer\u2018s disease. Dement Geriatr Cogn Disord 2004; 17: 91\u20139","DOI":"10.1159\/000074280"},{"key":"10.3238\/arztebl.2017.0447_ref58","unstructured":"Miller MC: What is reminiscence therapy? Harv Ment Health Lett 2009; 25: 8."},{"key":"10.3238\/arztebl.2017.0447_ref59","doi-asserted-by":"crossref","unstructured":"Gitlin LN, Winter L, Burke J, et al.: Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot study. Am J Geriatr Psychiatry 2008; 16: 229\u201339","DOI":"10.1097\/01.JGP.0000300629.35408.94"},{"key":"10.3238\/arztebl.2017.0447_ref60","doi-asserted-by":"crossref","unstructured":"Eggermont LHP, Scherder EJA: Physical activity and behaviour in dementia: a review of the literature and implications for psychosocial intervention in primary care. Dementia 2006; 5: 411\u201328","DOI":"10.1177\/1471301206067115"},{"key":"10.3238\/arztebl.2017.0447_ref61","doi-asserted-by":"crossref","unstructured":"Raglio A, Bellelli G, Traficante D, et al.: Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. Alzheimer Dis Assoc Disord 2008; 22: 158\u201362","DOI":"10.1097\/WAD.0b013e3181630b6f"},{"key":"10.3238\/arztebl.2017.0447_ref62","unstructured":"Romero B: Kommunikation in der Therapie und in der Betreuung von Demenzkranken. Aphasie und verwandte Gebiete 2002; 3: 7\u201320."},{"key":"10.3238\/arztebl.2017.0447_ref63","doi-asserted-by":"crossref","unstructured":"Romero B: Selbsterhaltungstherapie: Konzept, klinische Praxis und bisherige Ergebnisse. ZfGP 2004; 17: 119\u201334.","DOI":"10.1024\/1011-6877.17.2.119"},{"key":"10.3238\/arztebl.2017.0447_ref64","doi-asserted-by":"crossref","unstructured":"Rusted J, Sheppard L, Waller D: A multi-centre randomized control group trial on the use of art therapy for older people with dementia. Group Analysis 2006; 39: 517\u201336","DOI":"10.1177\/0533316406071447"},{"key":"10.3238\/arztebl.2017.0447_ref65","doi-asserted-by":"crossref","unstructured":"Ball J, Haight BK: Creating a multisensory environment for dementia: the goals of a Snoezelen room. J Gerontol Nurs 2005; 31: 4\u201310.","DOI":"10.3928\/0098-9134-20051001-04"},{"key":"10.3238\/arztebl.2017.0447_ref66","doi-asserted-by":"crossref","unstructured":"Forrester LT, Maayan N, Orrell M, et al.: Aromatherapy for dementia. Cochrane Database Syst Rev 2014; (2): CD003150.","DOI":"10.1002\/14651858.CD003150.pub2"},{"key":"10.3238\/arztebl.2017.0447_ref67","doi-asserted-by":"crossref","unstructured":"Remington R: Calming music and hand massage with agitated elderly. Nurs Res 2002; 51: 317\u201323","DOI":"10.1097\/00006199-200209000-00008"},{"key":"10.3238\/arztebl.2017.0447_ref68","doi-asserted-by":"crossref","unstructured":"Chung JC, Lai CK, Chung PM, French HP: Snoezelen for dementia. Cochrane Database Syst Rev 2002; (4): CD003152","DOI":"10.1002\/14651858.CD003152"},{"key":"10.3238\/arztebl.2017.0447_ref69","doi-asserted-by":"crossref","unstructured":"Livingston G, Johnston K, Katona C, et al.: Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry 2005; 162: 1996\u20132021","DOI":"10.1176\/appi.ajp.162.11.1996"},{"key":"10.3238\/arztebl.2017.0447_ref70","doi-asserted-by":"crossref","unstructured":"Beuscher L, Grando VT: Challenges in conducting qualitative research with individuals with dementia. Res Gerontol Nurs 2009; 2: 6\u201311","DOI":"10.3928\/19404921-20090101-04"},{"key":"10.3238\/arztebl.2017.0447_ref71","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWIG) (ed.): Nichtmedikament\u00f6se Behandlung der Alzheimer Demenz. Abschlussbericht A05\u201319C. K\u00f6ln: IQWiG 2009."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:27:53Z","timestamp":1638872873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,30]]},"references-count":71,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2017.0447","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,30]]}}}